TrialBlood2013

Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities.

Preetesh Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.